Dose-Effect Response in Acupuncture for Functional Constipation

Recruiting now · Not applicable

Conditions studied: Functional Constipation (FC)

In brief

This is a single-center, randomized, parallel-group trial evaluating the dose-response relationship of two experimental interventions: manual acupuncture and electroacupuncture for functional constipation. A total of 72 participants with functional constipation (Rome IV criteria) will be randomly assigned in a 1:1 ratio to either the manual acupuncture group or the electroacupuncture group. Both groups receive acupuncture at bilateral Tianshu (ST25) and Shangjuxu (ST37) points, 30 minutes per session, three times per week for 12 weeks. The electroacupuncture group additionally receives electrical stimulation (continuous wave, 10 Hz, 0.5-4 mA). The primary outcome is the responder rate at week 12, defined as the percentage of participants with ≥3 complete spontaneous bowel movements (CSBMs) per week. Secondary outcomes include changes in gut microbiota, brain functional connectivity measured by multimodal MRI and fNIRS, and scales. The study aims to clarify the dose-response characteristics of different acupuncture modalities and their underlying biological mechanisms.

Key facts

Study ID

NCT07506122

Run by

Tongji Hospital

People needed

72

Starts

2026-05-11

Expected to finish

2027-12-01

Last updated by the study team

2026-05-14

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet Rome IV diagnostic criteria for functional constipation
• Symptoms present for ≥6 months, meeting diagnostic criteria in the last 3 months
• Mean weekly complete spontaneous bowel movements (CSBMs) ≤2 during 14-day baseline period
• Age 18-75 years
• No use of constipation medications for at least 2 weeks prior to treatment (except rescue medication)
• No acupuncture treatment for constipation in the past 3 months
• Not currently participating in another clinical trial
• Willing and able to provide written informed consent

You may not qualify if…

• Constipation secondary to other causes (IBS, organic diseases, medications, endocrine disorders, metabolic disorders, neurological disorders, or gastrointestinal surgery)
• Loose or watery stools (Bristol type 6 or 7) >1 time during baseline without laxative use
• History of pelvic floor dysfunction
• Use of probiotics, fiber supplements, or laxatives within 2 weeks prior to treatment (2-week washout required)
• Severe hemorrhoids or anal fissures
• Severe or uncontrolled heart, liver, or kidney disease; abdominal aortic aneurysm; hepatosplenomegaly; cognitive impairment; or psychiatric disorders
• Dependence on opioids or anticholinergic drugs
• Red flags: unexplained weight loss >10% in 3 months, hematochezia or positive fecal occult blood, family history of colon cancer (first-degree relative diagnosed <50 years), anemia (Hb <110 g/L), or elevated inflammatory markers
• Contraindications to acupuncture: coagulation disorders or use of anticoagulants
• Pregnancy or breastfeeding
• Unable to comply with follow-up or contraindications to MRI (e.g., cardiac pacemaker, non-titanium aneurysm clips, metallic implants, claustrophobia)

Where it is running

• Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology — Wuhan, Hubei, China (enrolling)
• Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology — Wuhan, Hubei, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.